《New Genetics And Society》重点专注发布生物-生物工程与应用微生物领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在生物-生物工程与应用微生物领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 4.3 | 0.415 | 0.932 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Nursing
小类：小类：Issues,EthicsandLegalAspects
|
Q1 | 11/46 | 77% | |||
|
大类：大类：Nursing
小类：小类：Health(socialscience)
|
Q2 | 97/371 | 73% | |||
|
大类：大类：Nursing
小类：小类：HealthPolicy
|
Q2 | 93/310 | 70% | |||
|
大类：大类：Nursing
小类：小类：Genetics
|
Q3 | 196/347 | 43% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | 158 / 174 | 9.5% |
| 学科：GENETICS & HEREDITY | SCIE | Q4 | 156 / 191 | 18.6% |
| 学科：HISTORY & PHILOSOPHY OF SCIENCE | SSCI | Q1 | 25 / 104 | 76.4% |
| 学科：SOCIAL ISSUES | SSCI | Q3 | 35 / 67 | 48.5% |
| 学科：SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | 37 / 46 | 20.7% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | 87 / 174 | 50.29% |
| 学科：GENETICS & HEREDITY | SCIE | Q3 | 101 / 191 | 47.38% |
| 学科：HISTORY & PHILOSOPHY OF SCIENCE | SSCI | Q2 | 40 / 104 | 62.02% |
| 学科：SOCIAL ISSUES | SSCI | Q3 | 35 / 67 | 48.51% |
| 学科：SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q3 | 31 / 46 | 33.7% |
文章名称
引用次数
Governing anticipatory technology practices. Forensic DNA phenotyping and the forensic genetics community in Europe
10
Extending experimentation: oncologys fading boundary between research and care
9
Contested futures: envisioning Personalized, Stratified, and Precision medicine
8
Genomic research and the cancer clinic: uncertainty and expectations in professional accounts
6
Forensic DNA phenotyping in Europe: views on the ground from those who have a professional stake in the technology
6
Consumer (dis-)interest in genetic ancestry testing: the roles of race, immigration, and ancestral certainty
5
Knowing something versus feeling different: the effects and non-effects of genetic ancestry on racial identity
4
Organizational challenges to equity in the delivery of services within a new personalized risk-based approach to breast cancer screening
3
Clinical and personal utility of genomic high-throughput technologies: perspectives of medical professionals and affected persons
3
Realizing responsibility. Institutional routines, critical intervention, and the big questions in the controversy over non-invasive prenatal testing in Germany
3
国家/地区
发文量
TEngland
39
TUSA
27
TScotland
13
TCanada
10
TFrance
8
TIsrael
8
TGERMANY (FED REP GER)
6
TSwitzerland
6
TDenmark
5
TAustralia
3
